Curative Biotechnology Valuation
| CUBT Stock | USD 0.01 0.0001 1.14% |
Curative Biotechnology seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Curative Biotechnology from analyzing the firm fundamentals such as Current Valuation of 9.18 M, return on equity of -3.98, and Shares Owned By Insiders of 0.05 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Curative Biotechnology's valuation include:
Enterprise Value 9.2 M | Enterprise Value Ebitda (3.88) | Price Sales 158.5303 |
Overvalued
Today
Please note that Curative Biotechnology's price fluctuation is out of control at this time. Calculation of the real value of Curative Biotechnology is based on 3 months time horizon. Increasing Curative Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Curative Biotechnology's intrinsic value may or may not be the same as its current market price of 0.01, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0087 | Real 0.007306 | Hype 0.009191 |
The intrinsic value of Curative Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Curative Biotechnology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Curative Biotechnology helps investors to forecast how Curative stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Curative Biotechnology more accurately as focusing exclusively on Curative Biotechnology's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Curative Biotechnology's intrinsic value based on its ongoing forecasts of Curative Biotechnology's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Curative Biotechnology's closest peers.
Curative Biotechnology Cash |
|
Curative Valuation Trend
Curative Biotechnology's real value is important for investors to make better decisions and a more accurate overall view of Curative Biotechnology's financial worth over time. Using both Curative Biotechnology's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Curative Biotechnology Total Value Analysis
Curative Biotechnology is currently forecasted to have valuation of 9.18 M with market capitalization of 7.91 M, debt of 2.26 M, and cash on hands of 126.85 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Curative Biotechnology fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.18 M | 7.91 M | 2.26 M | 126.85 K |
Curative Biotechnology Investor Information
The company recorded a loss per share of 0.01. Curative Biotechnology had not issued any dividends in recent years. The entity had 1:400 split on the 2nd of December 2022. Based on the key measurements obtained from Curative Biotechnology's financial statements, Curative Biotechnology may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.Curative Biotechnology Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Curative Biotechnology has an asset utilization ratio of 5.08 percent. This implies that the Company is making $0.0508 for each dollar of assets. An increasing asset utilization means that Curative Biotechnology is more efficient with each dollar of assets it utilizes for everyday operations.Curative Biotechnology Ownership Allocation
Curative Biotechnology holds a total of 903.26 Million outstanding shares. Almost 99.95 percent of Curative Biotechnology outstanding shares are held by general public with 0.051 (percent) owned by insiders and only 0.0 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Curative Biotechnology Profitability Analysis
The company reported the previous year's revenue of 132.32 K. Net Loss for the year was (3.96 M) with profit before overhead, payroll, taxes, and interest of 100.21 K.About Curative Biotechnology Valuation
The stock valuation mechanism determines Curative Biotechnology's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Curative Biotechnology based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Curative Biotechnology. We calculate exposure to Curative Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Curative Biotechnology's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -97.5 K | -92.6 K | |
| Pretax Profit Margin | (1.80) | (1.71) | |
| Operating Profit Margin | (0.16) | (0.17) | |
| Net Loss | (1.80) | (1.71) | |
| Gross Profit Margin | 0.87 | 0.69 |
Curative Biotechnology Growth Indicators
Investing in growth stocks can be very risky. If the company such as Curative Biotechnology does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 662.2 M |
Curative Biotechnology Current Valuation Indicators
Curative Biotechnology's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Curative Biotechnology's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Curative Biotechnology, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Curative Biotechnology's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Curative Biotechnology's worth.Additional Tools for Curative Stock Analysis
When running Curative Biotechnology's price analysis, check to measure Curative Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biotechnology is operating at the current time. Most of Curative Biotechnology's value examination focuses on studying past and present price action to predict the probability of Curative Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biotechnology's price. Additionally, you may evaluate how the addition of Curative Biotechnology to your portfolios can decrease your overall portfolio volatility.